Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)

China flag China · Delayed Price · Currency is CNY
59.02
-2.89 (-4.67%)
May 12, 2026, 3:04 PM CST
Market Cap7.67B -4.0%
Revenue (ttm)1.20B -4.7%
Net Income226.55M -16.1%
EPS1.74 -15.5%
Shares Out129.95M
PE Ratio33.85
Forward PE28.38
Dividend0.50 (0.81%)
Ex-Dividend DateMay 20, 2025
Volume3,286,887
Average Volume2,237,292
Open58.97
Previous Close61.91
Day's Range58.88 - 61.33
52-Week Range51.53 - 94.30
Beta0.57
RSI51.21
Earnings DateApr 21, 2026

About SHE:300841

Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines. In addition, it exports its products. Chengdu Kanghua Biological Products Co., Ltd. was founded in 2004 and is based in Chengdu, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 550
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300841
Full Company Profile

Financial Performance

In 2025, SHE:300841's revenue was 1.17 billion, a decrease of -18.64% compared to the previous year's 1.43 billion. Earnings were 219.90 million, a decrease of -44.84%.

Financial Statements